Navigation Links
SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.
Date:9/22/2011

GERMANTOWN, Md., Sept. 22, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, today announced that Neil J. Campbell, president and CEO, will be presenting at AdvaMed 2011: The Medtech Conference in Washington, D.C. on September 27, 2011 at 11:00 a.m. in room 204A of the Walter E. Washington Convention Center in Washington, D.C.  

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology targeting four industry sectors: human health, animal health, industrial and biodefense/biosecurity.

"AdvaMed 2011 is the premier event for investors and leaders in the medical technology industry, and thus is an ideal opportunity for SuperNova to showcase its game-changing, disruptive technology and 'lab-in-the-palm-of-your-hand' diagnostic system," said Mr. Campbell.  "With our proprietary AmpCrystal® platform, which provides an array of diagnostic capabilities from patient treatment to pathogen detection, SuperNova has the potential to seize the still largely untapped multi-billion dollar point-of-care and point-of-use diagnostic market."

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando / Madeleine Desmond
(212) 827-0020
jrando@tiberend.com / mdesmond@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics(R), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China to Commercialise Neopterin Diagnostics
2. SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
3. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
4. InterMune to Present at Canaccord Adams Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
6. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
8. Bionovo to Present at Canaccord Adams Global Growth Conference
9. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
10. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
11. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The Foundation for ... partnerships, seeks outstanding early career nominees for the 2017 New Innovator in Food ... needs of a world in which one in nine people suffers from hunger. ...
(Date:1/24/2017)... January 23, 2017 According to ... by Type (Genetic, Cell-based (CD34, PBMC, BLT)), Application (Neuroscience, ... (Pharmaceutical & Biotech Companies, CRO) - Global Forecast to ... Humanized Mouse Model Market for the forecast period of ... USD 116.0 Million by 2021 from USD 73.3 Million ...
(Date:1/23/2017)... FORT LAUDERDALE, Fl (PRWEB) , ... January 23, ... ... Commission Accredited venture-backed teleradiology and telemedicine company announces significant growth last year adding ... customers include Veterans Authority and US Army medical centers as well as one ...
(Date:1/23/2017)... England , January 23, 2017 ... today announces completion of its Series D financing, raising $35 ... one new investor, Wondfo Biotech. ... Development of the Atlas Genetics io® ... the Chlamydia trachomatis (CT) test announced in February 2016.  This ...
Breaking Biology Technology:
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... and Forecasts, 2015 - 2022," projects that the global biometric technology market is expected ... from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
Breaking Biology News(10 mins):